Court favors Medica in copyright suit against Diamond Diagnostics

By Mass High Tech staff

Video Gallery

Funding drugs for rare diseases

MHT's Julie Donnelly: Life science startups finding investments

MHT's Marc Songini: Researchers focus on macular degeneration

Related News

Post-buyout, Atrium Medical plans new site [February 10, 2012]

Hologic, Conceptus both file appeals in patent case [February 9, 2012]

Harvard Bioscience buys German lab product maker [February 8, 2012]

NeuroMetrix eyes $10.5M from securities offering [February 8, 2012]

Ocular Therapeutix advances eye sealant to trial [February 7, 2012]

Medica Corp. has won a copyright lawsuit brought against Holliston-based Diamond Diagnostics Inc.

The U.S. District Court in Boston has ruled that Diamond Diagnostics must pay for damages and must agree to a permanent injunction. Medica filed suit against the company alleging pirated copies of Medica’s EasyLyte software were incorporated in Diamond’s Prolyte Electrolyte Analyzer.

The Court’s injunction prohibits Diamond from selling its Prolyte Electrolyte Analyzer product with Medica’s software and also prohibited the use of text, drawings and illustrations, originated by Medica, for use in the Prolyte operator’s manual.

Founded in 1984, Bedford-based Medica develops and commercializes in vitro diagnostic medical devices.

Diamond Diagnostics is a manufacturing and refurbishing company focused on electrolyte, blood gas, chemistry, immunology, hematology and coagulation instrumentation.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.